Adaptive Biotechnologies Corp (ADPT) stock
ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$28.46−0.03 (-0.11%)
Close on Nov 18, 2026Market cap $4.54BP/E –Yield –
Adaptive Biotechnologies market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Adaptive Biotechnologies's market cap was $4.76B on Nov 11, 2026, against $3.00B a year earlier. Over the last 5 years it ranged from $380.12M to $4.76B, with a median of $1.22B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $4.76B | +92.2% |
| 2025 | Dec 31, 2025 | $2.48B | +180.1% |
| 2024 | Dec 31, 2024 | $884.63M | +24.7% |
| 2023 | Dec 29, 2023 | $709.39M | -35.1% |
| 2022 | Dec 30, 2022 | $1.09B | -72.4% |
| 2021 | Dec 31, 2021 | $3.96B | -50.9% |
| 2020 | Dec 31, 2020 | $8.06B | +116.8% |
| 2019 | Dec 31, 2019 | $3.72B | – |
See a number that looks wrong?